Los Angeles Capital Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.8K | Hold |
647
| – | – | ﹤0.01% | 1585 |
|
|
2025
Q4 | $39.4K | Buy |
+647
| New | +$39.3K | ﹤0.01% | 1673 |
|
|
2025
Q2 | – | Sell |
-7,335
| Closed | -$430K | – | 1454 |
|
|
2025
Q1 | $430K | Buy |
+7,335
| New | +$497K | ﹤0.01% | 786 |
|
|
2023
Q2 | – | Sell |
-38,796
| Closed | -$2.88M | – | 1287 |
|
|
2023
Q1 | $2.88M | Sell |
38,796
-29,780
| -43% | -$2.3M | 0.01% | 426 |
|
|
2022
Q4 | $5.68M | Sell |
68,576
-96
| -0.1% | -$7.62K | 0.03% | 360 |
|
|
2022
Q3 | $4.88M | Buy |
68,672
+21,348
| +45% | +$1.84M | 0.03% | 366 |
|
|
2022
Q2 | $4.1M | Buy |
47,324
+13,280
| +39% | +$1.24M | 0.02% | 388 |
|
|
2022
Q1 | $3.69M | Buy |
34,044
+800
| +2% | +$82.5K | 0.01% | 410 |
|
|
2021
Q4 | $4.3M | Buy |
33,244
+872
| +3% | +$107K | 0.02% | 369 |
|
|
2021
Q3 | $3.92M | Buy |
32,372
+5,804
| +22% | +$706K | 0.02% | 392 |
|
|
2021
Q2 | $2.99M | Buy |
26,568
+2,932
| +12% | +$309K | 0.01% | 485 |
|
|
2021
Q1 | $2.26M | Buy |
23,636
+4,280
| +22% | +$390K | 0.01% | 587 |
|
|
2020
Q4 | $1.54M | Sell |
19,356
-1,532
| -7% | -$111K | 0.01% | 758 |
|
|
2020
Q3 | $1.29M | Buy |
20,888
+432
| +2% | +$28.1K | 0.01% | 719 |
|
|
2020
Q2 | $1.35M | Buy |
20,456
+1,100
| +6% | +$65.9K | 0.01% | 732 |
|
|
2020
Q1 | $918K | Hold |
19,356
| – | – | 0.01% | 734 |
|
|
2019
Q4 | $1.06M | Sell |
19,356
-25,492
| -57% | -$1.34M | 0.01% | 820 |
|
|
2019
Q3 | $2.19M | Hold |
44,848
| – | – | 0.01% | 605 |
|
|
2019
Q2 | $2.34M | Sell |
44,848
-6,520
| -13% | -$329K | 0.01% | 609 |
|
|
2019
Q1 | $2.55M | Buy |
51,368
+5,320
| +12% | +$239K | 0.01% | 588 |
|
|
2018
Q4 | $1.67M | Hold |
46,048
| – | – | 0.01% | 602 |
|
|
2018
Q3 | $2.35M | Buy |
46,048
+3,048
| +7% | +$135K | 0.01% | 628 |
|
|
2018
Q2 | $1.59M | Hold |
43,000
| – | – | 0.01% | 763 |
|
|
2018
Q1 | $1.62M | Sell |
43,000
-149,832
| -78% | -$5.29M | 0.01% | 696 |
|
|
2017
Q4 | $6.25M | Hold |
192,832
| – | – | 0.03% | 414 |
|
|
2017
Q3 | $5.83M | Hold |
192,832
| – | – | 0.03% | 406 |
|
|
2017
Q2 | $5.66M | Buy |
192,832
+68,632
| +55% | +$1.88M | 0.04% | 415 |
|
|
2017
Q1 | $3.16M | Buy |
124,200
+55,952
| +82% | +$1.44M | 0.02% | 488 |
|
|
2016
Q4 | $1.75M | Hold |
68,248
| – | – | 0.01% | 573 |
|
|
2016
Q3 | $1.87M | Sell |
68,248
-400
| -0.6% | -$11K | 0.02% | 588 |
|
|
2016
Q2 | $1.94M | Sell |
68,648
-14,440
| -17% | -$371K | 0.02% | 544 |
|
|
2016
Q1 | $1.96M | Sell |
83,088
-400
| -0.5% | -$8.81K | 0.02% | 469 |
|
|
2015
Q4 | $1.88M | Sell |
83,488
-34,872
| -29% | -$795K | 0.02% | 524 |
|
|
2015
Q3 | $2.74M | Sell |
118,360
-14,400
| -11% | -$361K | 0.03% | 468 |
|
|
2015
Q2 | $3.27M | Hold |
132,760
| – | – | 0.03% | 451 |
|
|
2015
Q1 | $3.33M | Buy |
132,760
+6,720
| +5% | +$160K | 0.03% | 445 |
|
|
2014
Q4 | $2.91M | Sell |
126,040
-640
| -0.5% | -$14.6K | 0.03% | 404 |
|
|
2014
Q3 | $2.96M | Buy |
+126,680
| New | +$2.97M | 0.04% | 373 |
|
Other funds holding TECH
VCM
VPM
MC
Los Angeles Capital Management's TECH Position: Q1 2026 in Review
Los Angeles Capital Management held its Bio-Techne (TECH) position steady in Q1 2026 at 647 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.
Los Angeles Capital Management first reported a position in TECH in Q3 2014 and has held it in 38 quarters since. The position peaked at $6.25M in Q4 2017. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Los Angeles Capital Management held 647 shares of Bio-Techne worth $33.8K as of Q1 2026.
- Los Angeles Capital Management left its Bio-Techne share count unchanged in Q1 2026.
- Bio-Techne made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1585 holding.
- Los Angeles Capital Management first reported a position in Bio-Techne in Q3 2014 and has held it in 38 quarters since.
- Los Angeles Capital Management's Bio-Techne position peaked at $6.25M in Q4 2017.
- 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.